The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapy

Tekijä Ahmad, Shamaila Munir, Martinenaite, Evelina, Holmström, Morten, Jørgensen, Mia Aaboe, Met, Özcan, Nastasi, Claudia, Klausen, Uffe, Donia, Marco, Pedersen, Lars Møller, Munksgaard, Lars, Ødum, Niels, Woetmann, Anders, Svane, Inge Marie, Andersen, Mads Hald
Julkaisussa Oncoimmunology (2017)

Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma

Tekijä Taskinen, Minna, Louhimo, Riku, Koivula, Satu, Chen, Ping, Rantanen, Ville, Holte, Harald, Delabie, Jan, Karjalainen-Lindsberg, Marja-Liisa, Björkholm, Magnus, Fluge, Øystein, Pedersen, Lars Møller, Fjordén, Karin, Jerkeman, Mats, Eriksson, Mikael, Hautaniemi, Sampsa, Leppä, Sirpa
Julkaistu 2014

The FIB-PPH trial: fibrinogen concentrate as initial treatment for postpartum haemorrhage: study protocol for a randomised controlled trial

Tekijä Wikkelsoe, Anne Juul, Afshari, Arash, Stensballe, Jakob, Langhoff-Roos, Jens, Albrechtsen, Charlotte, Ekelund, Kim, Hanke, Gabriele, Sharif, Heidi Fosgrau, Mitchell, Anja U, Svare, Jens, Troelstrup, Ane, Pedersen, Lars Møller, Lauenborg, Jeannet, Madsen, Mette Gøttge, Bødker, Birgit, Møller, Ann M
Julkaistu 2012

Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union

Tekijä Jürgen Rehm, Peter Anderson, Jose Angel Arbesu Prieto, Iain Armstrong, Henri-Jean Aubin, Michael Bachmann, Nuria Bastida Bastus, Carlos Brotons, Robyn Burton, Manuel Cardoso, Joan Colom, Daniel Duprez, Gerrit Gmel, Antoni Gual, Ludwig Kraus, Reinhold Kreutz, Helena Liira, Jakob Manthey, Lars Møller, Ľubomír Okruhlica, Michael Roerecke, Emanuele Scafato, Bernd Schulte, Lidia Segura-Garcia, Kevin David Shield, Cristina Sierra, Konstantin Vyshinskiy, Marcin Wojnar, José Zarco
Julkaistu 2017-09-01